Inspec

Inspec Change in Working Capital

The Change in Working Capital of Inspec (6656.T) as of Oct 21, 2026 is -686.88 M JPY. In the previous year, Change in Working Capital was 271.90 M JPY — a change of -352.62% (lower).

Change in Working Capital

-686.88 MJPY

YoY

-352.62%

Last updated:

Change in Working Capital of Inspec is 2026 -686.88 M JPY. Change in Working Capital of Inspec was 2025 271.90 M JPY. It decreases by -352.62% lower compared to the previous year.

The Inspec Change in Working Capital history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Change in Working Capital
Date
Change in Working Capital
Jan 1, 2019
65.70 M JPY
Jan 1, 2020
-59.89 M JPY
Jan 1, 2021
-28.09 M JPY
Jan 1, 2022
-394.11 M JPY
Jan 1, 2023
-925.13 M JPY
Jan 1, 2024
166.77 M JPY
Jan 1, 2025
271.90 M JPY
Jan 1, 2026
-686.88 M JPY
The Inspec Change in Working Capital history
YEARChange in Working CapitalYoY
-686.88 MJPY-352.62%
271.90 MJPY+63.04%
166.77 MJPY-118.03%
-925.13 MJPY+134.74%
-394.11 MJPY+1,302.92%
-28.09 MJPY-53.09%
-59.89 MJPY-191.15%
65.70 MJPY-119.02%
-345.40 MJPY-376.26%
125.02 MJPY+14.23%
109.45 MJPY-143.89%
-249.36 MJPY-9.27%
-274.83 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Inspec Stock analysis

What does Inspec do? inspec Inc. generates revenue through three primary segments. The Semiconductor Package Substrates and Precision Substrate Inspection Equipment segment sells appearance inspection equipment for semiconductor package substrates and precision printed circuit boards used in smartphones, tablets, PCs, and wearable terminals. The Precision Substrate Manufacturing Equipment segment provides photoplotters, inkjet printers, and direct imaging devices along with maintenance services for printed circuit boards. The Digital Pathology Related Equipment segment develops and sells medical image processing systems, specifically whole slide imaging (WSI) for digital pathology applications. Customers include manufacturers of advanced digital devices requiring semiconductor inspection, PCB producers needing photoplotters and imaging devices, and healthcare providers utilizing whole slide imaging systems for pathology diagnostics. The company's products target the semiconductor, electronics manufacturing, and medical imaging sectors with specific applications in device assembly, PCB production, and medical diagnostics. inspec Inc. focuses on equipment for semiconductor package substrates, precision substrates, and digital pathology, serving clients in the electronics and healthcare industries. The firm's inspection and imaging solutions are tailored to meet the quality control needs of high-tech manufacturing and medical diagnostics, with no mention of additional revenue streams beyond these three segments. Inspec is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Inspec stock

Change in Working Capital of Inspec is -686.88 M JPY in 2026.

Change in Working Capital of Inspec changed from 271.90 M JPY to -686.88 M JPY, representing a -352.62% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Change in Working Capital Inspec since 2006 – with annual values, charts, and detailed analysis.

Change in working capital reflects the period-over-period change in current assets minus current liabilities. It impacts operating cash flow significantly.

Change in Working Capital's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Change in Working Capital's Inspec historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Inspec

All Key Metrics — Inspec